Trade Summary

5 days ago, Gagnon Robert E., serving as CFO at Opus Genetics, Inc. (IRD), sold 7,842 shares at $5.18 per share, for a total transaction value of $40,658.00. Following this transaction, Gagnon Robert E. now holds 592,158 shares of IRD.

This sale represents a 1.00% decrease in Gagnon Robert E.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, April 23, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 27, 2026, 4 days after the trade was made.

Opus Genetics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.